171 related articles for article (PubMed ID: 20126997)
1. In vitro modulation of MMP-2 and MMP-9 in human cervical and ovarian cancer cell lines by cytokines, inducers and inhibitors.
Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2010 Mar; 23(3):605-14. PubMed ID: 20126997
[TBL] [Abstract][Full Text] [Related]
2. Cytokines, inducers and inhibitors modulate MMP-2 and MMP‑9 secretion by human Fanconi anemia immortalized fibroblasts.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2017 Mar; 37(3):1842-1848. PubMed ID: 28098879
[TBL] [Abstract][Full Text] [Related]
3. In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Roomi MW; Kalinovsky T; Monterrey J; Rath M; Niedzwiecki A
Int J Oncol; 2013 Dec; 43(6):1787-98. PubMed ID: 24085323
[TBL] [Abstract][Full Text] [Related]
4. Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2017 Mar; 37(3):1907-1913. PubMed ID: 28112361
[TBL] [Abstract][Full Text] [Related]
5. In vitro modulation of MMP-2 and MMP-9 in pediatric human sarcoma cell lines by cytokines, inducers and inhibitors.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Int J Oncol; 2014 Jan; 44(1):27-34. PubMed ID: 24190483
[TBL] [Abstract][Full Text] [Related]
6. Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2017 Jun; 37(6):3681-3687. PubMed ID: 28440509
[TBL] [Abstract][Full Text] [Related]
7. Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.
Roomi MW; Monterrey JC; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2009 Dec; 22(6):1283-91. PubMed ID: 19885578
[TBL] [Abstract][Full Text] [Related]
8. Modulation of human renal cell carcinoma 786-0 MMP-2 and MMP-9 activity by inhibitors and inducers in vitro.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Med Oncol; 2006; 23(2):245-50. PubMed ID: 16720925
[TBL] [Abstract][Full Text] [Related]
9. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human female cancer cell lines.
Roomi MW; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2012 Sep; 28(3):768-76. PubMed ID: 22736175
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of EGCG, green tea and a nutrient mixture on the patterns of MMP-2 and MMP-9 expression in cancer cell lines.
Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2010 Sep; 24(3):747-57. PubMed ID: 20664983
[TBL] [Abstract][Full Text] [Related]
11. Suppression of human cervical cancer cell lines Hela and DoTc2 4510 by a mixture of lysine, proline, ascorbic acid, and green tea extract.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Int J Gynecol Cancer; 2006; 16(3):1241-7. PubMed ID: 16803512
[TBL] [Abstract][Full Text] [Related]
12. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.
Mackay AR; Ballin M; Pelina MD; Farina AR; Nason AM; Hartzler JL; Thorgeirsson UP
Invasion Metastasis; 1992; 12(3-4):168-84. PubMed ID: 1284126
[TBL] [Abstract][Full Text] [Related]
13. Patterns of MMP-2 and MMP-9 expression in human cancer cell lines.
Roomi MW; Monterrey JC; Kalinovsky T; Rath M; Niedzwiecki A
Oncol Rep; 2009 May; 21(5):1323-33. PubMed ID: 19360311
[TBL] [Abstract][Full Text] [Related]
14. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines.
Hofmann A; Laue S; Rost AK; Scherbaum WA; Aust G
Thyroid; 1998 Mar; 8(3):203-14. PubMed ID: 9545106
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Oncol Rep; 2005 Feb; 13(2):253-7. PubMed ID: 15643507
[TBL] [Abstract][Full Text] [Related]
17. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
18. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2013 Jun; 42(6):1883-9. PubMed ID: 23563849
[TBL] [Abstract][Full Text] [Related]
19. Expression of matrix metalloproteinase-2 and -9 in human ligamentum flavum cells treated with tumor necrosis factor-α and interleukin-1β.
Kim BJ; Hur JW; Park JS; Kim JH; Kwon TH; Park YK; Moon HJ
J Neurosurg Spine; 2016 Mar; 24(3):428-35. PubMed ID: 26565765
[TBL] [Abstract][Full Text] [Related]
20. TGFbeta1 stimulates the secretion of matrix metalloproteinase 2 (MMP2) and the invasive behavior in human ovarian cancer cells, which is suppressed by MMP inhibitor BB3103.
Lin SW; Lee MT; Ke FC; Lee PP; Huang CJ; Ip MM; Chen L; Hwang JJ
Clin Exp Metastasis; 2000; 18(6):493-9. PubMed ID: 11592306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
